We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Progesterone Immunoassay Available in the United States

By LabMedica International staff writers
Posted on 14 Oct 2008
A progesterone immunoassay has been released for sale in the United States. More...
Progesterone and estrogen hormones regulate the accessory organs during the menstrual cycle and the establishment and maintenance of pregnancy.

Measurements of serum progesterone are also used to check the effectiveness of ovulation induction, to monitor progesterone replacement therapy, and to detect and evaluate patients at risk of spontaneous abortion during the early weeks of pregnancy. They are not considered a suitable means for monitoring fetal wellbeing during the third trimester.

Performed on the Olympus (Center Valley, PA, USA) AU3000i analyzer, the progesterone assay is a paramagnetic particle, chemiluminescent, competitive immunoassay with a measuring range of approximately 0.10-55 ng/ml. It measures quantitative concentrations of progesterone in either 10 µl of serum or lithium-heparin plasma samples after 28 minutes of processing time. The AU3000i system can automatically extend this range to measure samples with a progesterone concentration exceeding 55 ng/ml by diluting 20 µl samples at a ratio of 1:10 using the onboard Olympus sample diluent 3. Each progesterone kit is sufficient to process 100 tests, and contains progesterone reagents, a single ready-to-use calibrator, and a single ready-to-use control. Reagents are stable on board the AU3000i system for 28 days.

"The addition of the progesterone assay to the already available Olympus fertility assays luteinizing hormone (LH), follicle stimulating hormone (FSH), and prolactin is an important step in the development of a panel of tests comprising from 7-10% of the test volume in a routine clinical laboratory,” said Lorraine Damico, director of immunoassay marketing for Olympus America Inc.

Olympus Diagnostic Systems provides solutions that meet the high productivity demands of hospitals, integrated healthcare delivery networks, reference labs, blood banks, physician offices, and pharmaceutic labs. Olympus offers a standardized line of random access chemistry-immuno analyzers, along with lab automation systems, blood bank analyzers, and reagents.

Related LInks:
Olympus



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LiDia-SEQ aims to deliver near-patient NGS testing capabilities to hospitals, labs and clinics (Photo courtesy of DNAe)

World's First NGS-Based Diagnostic Platform Fully Automates Sample-To-Result Process Within Single Device

Rapid point-of-need diagnostics are of critical need, especially in the areas of infectious disease and cancer testing and monitoring. Now, a direct-from-specimen platform that performs genomic analysis... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.